Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,209,060 | 8,730,522 | 6,404,153 | 2,113,000 | 2,010,736 |
| Marketable Securities | 107,266 | 68,546 | 64,877 | 19,000 | 79,758 |
| Receivables | 2,850,367 | 3,436,711 | 3,236,195 | 2,182,000 | 1,971,926 |
| Inventories | 1,909,584 | 2,068,753 | 2,140,228 | 1,697,000 | 1,946,048 |
| Income taxes - deferred | 384,588 | 386,580 | 348,942 | 331,000 | 239,287 |
| Other current assets | 267,246 | 199,361 | 201,012 | 91,000 | 109,195 |
| TOTAL | $12,562,030 | $15,499,340 | $12,970,630 | $6,997,000 | $6,968,061 |
| Non-Current Assets | |||||
| PPE Net | 1,509,796 | 1,380,776 | 1,303,029 | 1,166,000 | 1,133,032 |
| Investments And Advances | 1,375,400 | 782,315 | 389,871 | 439,000 | 665,063 |
| Intangibles | 12,478,111 | 12,679,881 | 12,879,391 | 13,069,000 | 13,222,617 |
| Other Non-Current Assets | 919,053 | 863,858 | 534,769 | 908,000 | 479,658 |
| TOTAL | $16,282,360 | $15,706,830 | $15,107,060 | $15,582,000 | $15,500,370 |
| Total Assets | $28,844,390 | $31,206,160 | $28,077,690 | $22,579,000 | $22,468,430 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,477,082 | 1,572,079 | 1,871,811 | 2,697,000 | 1,457,379 |
| Accounts payable and accrued liabilities | 1,182,917 | 1,162,307 | 1,234,507 | 1,256,000 | 1,350,402 |
| Accrued Expenses | 2,009,428 | 1,826,648 | 1,320,892 | 1,261,000 | 1,132,666 |
| TOTAL | $6,054,952 | $6,227,997 | $5,914,776 | $6,407,000 | $4,895,124 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,415,582 | 8,106,732 | 8,106,977 | 3,939,000 | 6,117,184 |
| Deferred Revenues | 116,880 | 126,284 | 111,792 | 111,000 | 127,278 |
| Other Non-Current Liabilities | 451,815 | 380,113 | 275,785 | 410,147 | 122,979 |
| TOTAL | $8,925,830 | $8,548,825 | $8,460,722 | $4,427,000 | $6,380,831 |
| Total Liabilities | $14,980,780 | $14,776,820 | $14,375,500 | $10,834,000 | $11,275,960 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,508,664 | 1,511,670 | 1,535,682 | 1,538,253 | 1,533,349 |
| Common Shares | 1,514 | 1,526 | 1,538 | 2,000 | 763 |
| Retained earnings | 11,247,660 | 10,199,580 | 7,734,979 | 6,106,000 | 5,735,335 |
| Other shareholders' equity | 471,344 | 297,247 | 219,099 | 251,000 | 266,790 |
| TOTAL | $13,863,610 | $16,429,340 | $13,702,190 | $11,745,000 | $11,192,470 |
| Total Liabilities And Equity | $28,844,390 | $31,206,160 | $28,077,690 | $22,579,000 | $22,468,430 |